Gilead Sciences Inc. announced that Gregg Alton was appointed Chief Patient Officer, a newly created role that will facilitate access to the company’s medicines and increase focus on reaching patients. The company also announced that Diana Brainard, MD, was promoted to Senior Vice President, HIV and Emerging Viral Infections, and that Andrew Cheng, MD, PhD, Chief Medical Officer, decided to leave Gilead to pursue another opportunity.
GSW, a Syneos Health company and industry leader in healthcare advertising, named Crystal Derrick as VP, Managed Markets Strategy.
Ogilvy CommonHealth Worldwide, a WPP Health & Wellness company, announced five promotions and two new hires across multiple departments within the network’s New Jersey-based headquarters.
McCann Health promoted Connie Lo to president, McCann Health Greater China.
Intouch Solutions announced the hires of Paula Hackl, vice president of business transformations; Machelle Henks, vice president of strategic planning; Mendy McGuire, PharmD, vice president of medical strategy; and Mike Yonker, vice president of consulting and technology strategy in the firm’s Kansas City office.
Anthony Tartaglia, a technology executive with vast experience in consumer and healthcare brands, has been added to Razorfish Health’s leadership team as SVP, Digital Solutions.
Akouos, a precision genetic medicine company developing gene therapies that restore and preserve hearing, today announced that the company raised $50 million in Series A financing.
August 06, 2018 07:30 ET | Source: VIVUS, Inc. CAMPBELL, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) — VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced […]
CAMBRIDGE, England (PRWEB) August 02, 2018 Atlantic Healthcare plc (Atlantic Healthcare), a specialist gastrointestinal (GI) pharmaceutical company, developing treatments for inflammatory bowel disease and other GI diseases, has appointed […]
Navitor Pharmaceuticals Inc., a biopharmaceutical company targeting the mTORC1 pathway to develop novel therapeutics that help patients live longer and healthier lives, announced the appointment of Thomas E. Hughes, Ph.D., as Chief Executive Officer.
